LongeVC is a longevity-focused biotech VC founded in 2020. Fund I raised $25M, backed 20 portfolio companies, achieved 3x+ MOIC, and placed in the top quartile — with zero write-offs. Fund II is now targeting $120M with a $2M minimum LP commitment.
The focus is regenerative medicine, AI-driven drug discovery, and age-related diseases spanning cancer, neurodegeneration, metabolic disorders, and ca...
San Francisco, United States
Santa Monica, United States
New York, United States
San Francisco, United States
New York, United States
San Francisco, United States